Cochlear | COH - Stammkapital

Aktienkurs
94.99
Täglich Wechseln
-2.36 -2.42%
Monatlich
-43.09%
Jährlich
-64.61%
Q2 Prognose
95.52




Stammkapital Veränderung Datum
Ansell USD 142.94M 885.26M 2025-12
Cochlear AUD 65.4M 1.12B 2025-12
CSL USD 482.13M 93.87M 2025-12
Fisher Paykel Healthcare NZD 587.25M 1.35M 2025-12
Healius AUD 2.6B 100K 2024-12
Integral Diagnostics AUD 335.09M 1.07M 2024-06
Mayne Pharma AUD 81.25M 0 2025-06
Mesoblast USD 1.29B 8.58M 2025-12
Monash IVF AUD 389.63M 117.15M 2025-12
Nanosonics AUD 303.35M 188.61M 2025-12
Polynovo AUD 690.84M 991 2025-12
Ramsay Health Care AUD 229.93M 29.81K 2025-12
Regis Healthcare AUD 302.36M 1.11M 2025-12
ResMed USD 145.66M 279.42K 2025-12
Sigma Healthcare AUD 11.5B 9.93B 2025-12
Somnomed AUD 74.27M 0 2023-06
Sonic Healthcare AUD 4.15B 467K 2024-12
Telix Pharmaceuticals AUD 338.78M 379K 2025-12